Background ： Kidney tonifying -spleen strengthening method being one of the modalities for treatment of
Introduction
Male infertility is an unsolved worldwide problem. World Health Organization (WHO) statistics showed that infertility, cardiovascular disease and cancer have become the three major diseases affecting people's life and health in modern society (Kaminsky and Sperling, 2014) . The current situation of male reproductive health is not optimistic (Lu and Xie, 2001 ). In the past 50 years, sperm count and sperm quality both dropped substantially worldwide;
consequently, WHO has lowered the standard for semen quality more than once. The incidence of infertility has
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https://doi.org/10.21010/ajtcam.v14i4.11 88 increased from 8-10% half a century ago to 12-16% and it keeps increasing. It is estimated that approximately 80 million couples are infertile worldwide, of which 30% are due to male infertility. Various factors can lead to male infertility, while oligoasthenozoospermia is the most common cause (Guo and Zhang, 2011) .
Tripterygium glycosides (GTW) are commonly used to create animal models (Ma et al., 2015) . Mice treated with GTW had decreased sperm concentration and reduced sperm mobility, as well as sperm ultrastructural changes including damaged mitochondria sheath, cytoplasmic membrane defects and chromatin depolymerisation. This study aimed to investigate the mechanism of YiShenJianPi Recipe, used in Traditional Chinese Medicine to benefit "the kidney" and strengthen "the spleen", in the treatment of oligoasthenozoospermia. GTW was used to induce oligoasthenozoospermia in mice and the effect of YSJP Recipe on sperm quality, sperm mitochondrial membrane potential and sperm mitochondrial ultrastructure was examined. The mice were randomly divided into 5 groups (12 mice/group). GTW 40mg/kg (Anhui Xin Long Hai Pharmaceutical Co., Ltd.) was given once daily to the mice except those in the normal control group by intragastric administration for 4 weeks to induce oligoasthenozoospermia. For the next 4 weeks, the disease model group was given distilled water, the positive control group was given levocarnitine 10 mL/kg (Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd.), the low-dosage group was given YiShenJianPi Recipe 1.35 mg/kg, and the high-dosage group was given YiShenJianPi Recipe 2.70 mg/kg once daily. Mice in the normal control group were given distilled water for the whole time.
Material and Methods

Experimental animals and the treatments
YiShenJianPi Recipe was consisted of: seeds of Cuscuta chinensis 30 g, fruits of Lycium spp. 30 g, fruits of Schisandra spp. 10 g, roots of Codonopsis pilosula 10 g, unprocessed roots of Astragalus membranaceus 10 g, dried fruit skin of Citrus reticulata 10 g, roots or the whole plant of Bupleurum spp. 6 g, rhizome of Cimicifuga foetida 6 g, rhizome of Ligusticum chuanxiong 6 g and the flowers of Carthamus tinctorius 6 g (granules to make the decoction were provided by Beijing KangRenTang Ltd.).
The mice were sacrificed 30 min after the last administration by cervical dislocation. The testicles and the epididymides were collected and subjected to examinations.
Epididymis semen quality
The left epididymis was put into a test tube containing 1.0 mL saline (preheated to 37°C) and cut into small pieces.
The sperms were released by shaking the test tube. After incubated at 37°C for 15 min, the upper layer was carefully removed and centrifuged at 1500 rpm for 5 min. The pellet was resuspended in 1 mL BWW high protein capacitation solution and incubated at 37°C for 2 h. Sperm mobility, sperm concentration and the total number of sperms were measured using computer-aided sperm analysis (CASA; WLJU-9000 Weili Full Colour Sperm Quality Examination System, Beijing Weili New Century Science and Technology Development Co., Ltd., China). Sperms were categorised using the WHO 2009 standards (Li and Huang 2008) .
Sperm mitochondrial membrane potential
Sperms from the left epididymis were freed in 2.0 mL saline (preheated to 37°C) and incubated at 37°C for 15min. 
Ultrastructure of the sperms
Tissue samples from the head of the right epididymis (2 for each group) was made into 1 mm 3 cubes and fixed in 1.5 mL 2.5% glutaraldehyde fixing solution for 4 h. After washed in 0.1 mol/L PBS (pH 7.2) for 2 h, the samples were fixed again in 2.5% glutaraldehyde fixing solution for 2-4 h. Dehydration was carried out using gradient ethanol (30%, 50% and 70%) 15 min each. After immersed in a mixture of epoxy resin and acetone (1:1) at 37°C for 24 h, the samples were embedded in EPON 812 (145-160), dodecenyl succinic anhydride, methylcyclohexane-1,2-dicarboxylic anhydride and N,N-dimethylformamide at 60°C for 24 h. Semi-thin sections were prepared and stained with toluidine blue to localise the sections of interest using Olympus BX60 microscope (Olympus). Ultrathin sections (50-70 nm)
were prepared using LKB-NOVA Ultramicrotome (DAKO, Switzerland). Uranyl acetate and lead nitrate double staining was used. The ultrastructure of the sperms was observed using a transmission electron microscope (Hitachi HT7700, Japan) and the main focus was the changes in the mitochondria at the tail of the sperms.
Statistical analysis
SAS8.2 was used for data analyses. Numerical data were shown as mean ± standard deviation, using the single factor analysis of variance (one -way ANOVA) to compare between the multiple samples,the comparison between the two groups choose nonparametric test, with P < 0.05 for the difference was statistically significant.
Results
Sperm quality
At the end of the study, measurement of sperm quality of the mice in the disease model group showed that oligoasthenozoospermia was successfully included. Compared with the disease model group, the sperm quality of mice receiving treatment was significantly better (P<0.05 for all parameters, Figure 1 ). Compared with the positive control, mice in the low-dosage group had significantly better quality sperms (P<0.05 for all parameters, Figure 1 ), while the parameters in the high-dosage group were better but the differences were not significant (P>0.05 for all, Figure 1 ). The sperm concentration and the total number of sperm of the positive control were numerically lower than that of the YSJP low-and high-dosage groups (P>0.05, respectively; Figure 1 ), while those of the low-dosage group were numerically higher than the high-dose group (P>0.05, respectively; Figure 1 ). 
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Sperm mitochondrial membrane potential
The total number of sperms, showing as the blue and green dots in each panel in Figure 3 , was similar across the groups, which indicated that it was not affected by tripterygium glycosides and the treatments (levocarnitine 10 mL/kg, 
Ultrastructure of the sperms
The cross-section of the tail of the sperms in the normal control group showed the complete mitochondrial sheath structure surrounding the dense fibres and the axonemes. There were nine outer fibres, nine axonemes in the middle and two microtubules with clear structure in the centre, which formed the 9+2+2 structure ( Figure 4A ). For the disease control group, the whole mitochondria in the sperms were obvious swollen, the fibres were loose, and the axonemes were broken, with damaged 9+2+2 structure ( Figure 4B ). With treatment, compared with the disease control, the mitochondrial sheath structure was fairly complete, the whole mitochondria were less swollen, the arrangement of the fibres and the axonemes were less disrupted, and the 9+2+2 structure was clearly visible ( Figures 4C, 4D and 4E) . 
Discussion
In traditional Chinese medicine, the dried root or the woody part of the root of Tripterygium wilfordii is used to eliminate the wet, enhance the movement of blood and the circulation in the meridian system, reduce swelling and pain, kill parasites and remove any toxic elements (Gao 2007 ). Large amount of data from experimental and clinical studies have shown that any preparations using T. wilfordii and its various extracts have reproductive toxicity. Long-term intake of such preparations can induce oligozoospermia, asthenozoospermia or even azoospermia (Ma et al., 2011) .
Tripterygium glycosides (GTW) are refined fat-soluble extracts from the core of the root of T. wilfordii and with high polarity.
They are clinically used to treat rheumatoid arthritis, chronic kidney disease and other autoimmune diseases and demonstrate significant efficacy. However, their application was limited due to serious reproductive toxicity. Experimental studies have shown that GTW can cause epididymal sperm deformity, decreased sperm motility and density and the formation of vacuoles in the sperm mitochondrial sheath (Yamada et al., 2006) . It can also cause atrophy of the testicular seminiferous tubules, disarray of the seminiferous epithelial cells, decreased number of spermatocytes at all levels, decreased number of sperms and DNA damage of the testicular cells. It was also found that sperms in the testicles and epididymides were the target of GTW, and the severity of reproductive toxicity was positive correlated with the dose or GTW and exposure time (Li and Peng, 2008) . Previous studies carried out by our laboratory established that GTW 40mg/(kg·d) intragastric administration for 4 weeks could create a good model for oligoasthenozoospermia in rats (Ma et al. 2015) .
Mitochondria provide the energy for the movement of sperms (Nakata et al., 2015) . The swing of the tail makes the sperm moving forward, and the complete mitochondrial sheath structure is a guarantee for the energy source that facilitates the tail swinging. Studies showed that damaged mitochondrial structure at the middle of the sperm tail is the key for the loss of motility; other pathological changes, such as changes in the dense fibres of the axoneme inside the tail of the sperm, result in the inefficient usage of ATP leading to the decreased sperm motility or death (Dang et al., 2008; Hu et al., 2006) . Therefore, normal mitochondrial membrane potential and normal structure of the mitochondria at the middle of the sperm tail are the basis of normal sperm motility.
In Traditional Chinese Medicine, the essence is considered as the material basis to constitute the human body. The inborn essence is from the parents and stored in "the kidney" and the acquired essence is from the diet and is generated from "the spleen Hence, through using the Tonifying Kidney-Strengthening Spleen formula, we are able to achieve a desirable effect in a clinical setting in treating Astheno-oligozoospermia.
With the essence stored, "the kidney" is associated with reproductivity and being replenished constantly with acquired essence. Therefore, male fertility is closely related to "the spleen" and "the kidney". The inborn essence in "the kidney" and the acquired essence from "the spleen and the stomach" jointly promote the formation and maturation of the sperm. Thus, we believe that "spleen and kidney deficiency, essence lost its source" is the cause for oligoasthenozoospermia. Since the origin of the problem is in "the spleen" and "the kidney", the treatment should be design to benefit "the kidney", strengthen "the spleen" and replenish the essence. YiShenJianPi Recipe has been adapted from the classic recipe Wuziyanzong Pills, with Cu. chinensis, Lycium spp., Schisandra spp., Co. pilosula and A. membranaceus as the main ingredients. Wuziyanzong Pills can significantly improve sperm mitochondrial membrane potential and improve the ultrastructure of the mitochondria in the tail of the sperm , therefore improving sperm motility. In clinical practice, we use the recipe to treat oligoasthenozoospermia with satisfactory outcomes, sperm concentration and sperm mobility of the patients showed significant improvement (Ding et al., 2015) . However, in the current study we found that for mice with GTW-induced oligoasthenozoospermia, the improvement in sperm motility in the low-dosage YSJP treatment group was significantly better than that of the high-dosage YSJP treatment group (P<0.05); while our clinical data showed that high-dosage YSJP was more effective than low-dosage YSJP. One possible explanation is that for YSJP decoction to improve spermatogenesis and sperm maturation, an optimal concentration is required, and it is not necessarily that a higher concentration will lead to better efficacy outcome.
During data analysis, we have noticed some limitations of this study. For instance, since we used normal saline rather than cell culture medium to release sperms from the epididymides, the sperm motility might have been affected during this process. In addition, the instrument used for sperm analysis is designed for human sperm analysis and it may not be suitable for the analysis of mice sperm. Also, the effect of experimental error and a too small sample size could not be ruled out.
In conclusion, we have demonstrated that YiShenJianPi Recipe has antagonistic effect on the reproductive toxicity of tripterygium glycosides. It can increase spermatogenesis and improve semen quality by increasing mitochondrial membrane potential of the sperm and restoring the ultrastructure of the mitochondria present in the sperm tail. The current study has provided pathophysiological evidence to support the clinical use of YiShenJianPi Recipe in the treatment of oligoasthenozoospermia.
